Tumor-Infiltrating Lymphocyte Grade IDs Melanoma Survival
TIL grade is an independent predictor of sentinel lymph node status and survival in cutaneous melanoma.
Melanoma
Melanoma: Causes, Symptoms, and Prevention
This fact sheet offers tips to decrease the risk of malignant melanoma, the fastest growing forms of skin cancer.
New Peri-Op Approach Accurately IDs Melanoma in Nail Matrix
Reflectance confocal microscopy can be used to diagnose subungual melanomas of the nail matrix.
ASCO: First Mutated Gene Causing Familial Uveal Melanoma Identified
BAP1 causes familial uveal melanoma.
Biochemotherapy Improves Relapse-Free Survival in Patients with High-Risk Melanoma
Biochemotherapy (BCT) demonstrates greater improvement in relapse-free survival (RFS) compared to high-dose interferon (HDI).
Vemurafenib Improves Overall Survival in Patients with Metastatic Melanoma
Vemurafenib improved overall survival (OS) in patients with BRAF600E-mutated metastatic melanoma.
Slow-Growing Melanomas Lose Structure, Vary Color With Time
Little increase in lesion diameter, but structure, organization, and colors of lesions change for most slow-growing melanomas.
NSAID Use Linked to Reduced Risk of Skin Cancer
Lower risk of squamous cell carcinoma, malignant melanoma; notably in long-term, high-intensity use.
Vemurafenib, Dabrafenib Linked to Cutaneous Side Effects
Squamous cell carcinoma, warty dyskeratomas, verrucous keratoses, and other lesions can occur.
Injectable Melanoma Therapy to Move into Phase 3
Provectus Pharmaceuticals has received guidance from the FDA to move forward with Phase 3 clinical trials for PV-10 for melanoma.
- Loading...
Loading...
Next post in Skin Cancer
Loading... 
Loading...